"Aduromed has positioned itself to expand its presence in the industry and achieve ambitious goals in the coming years, and I believe
"Damien's enthusiasm and entrepreneurial spirit helped to create significant technology which Aduromed will now leverage to take to the next level," added
About Aduromed Industries, Inc.
Aduromed Industries, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. Aduromed's flagship MedClean(R) Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. Aduromed was founded in 1997 with corporate headquarters, research and development and distribution facilities located in
Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in our most recent Annual Report on Form 10-K for the year ended
Contacts: Aduromed Industries, Inc. Investor Contact: Kevin Dunphy Cameron Donahue Chief Financial Officer Hayden IR (203) 798-1080 (651) 653-1854 kdunphy@aduromed.com cameron@haydenir.com
SOURCE Aduromed Industries, Inc.